A detailed history of Oppenheimer Asset Management Inc. transactions in Vericel Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 15,850 shares of VCEL stock, worth $927,859. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,850
Previous 16,078 1.42%
Holding current value
$927,859
Previous $737,000 9.23%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$42.25 - $53.56 $9,633 - $12,211
-228 Reduced 1.42%
15,850 $669,000
Q2 2024

Aug 08, 2024

BUY
$41.71 - $52.9 $107,778 - $136,693
2,584 Added 19.15%
16,078 $737,000
Q1 2024

May 06, 2024

SELL
$32.52 - $52.33 $79,316 - $127,632
-2,439 Reduced 15.31%
13,494 $701,000
Q4 2023

Feb 13, 2024

SELL
$30.85 - $37.09 $10,890 - $13,092
-353 Reduced 2.17%
15,933 $567,000
Q3 2023

Nov 07, 2023

SELL
$31.69 - $39.25 $4,690 - $5,809
-148 Reduced 0.9%
16,286 $545,000
Q2 2023

Aug 02, 2023

BUY
$29.0 - $38.37 $16,356 - $21,640
564 Added 3.55%
16,434 $617,000
Q1 2023

May 10, 2023

BUY
$23.85 - $31.34 $51,921 - $68,227
2,177 Added 15.9%
15,870 $465,000
Q4 2022

Feb 06, 2023

SELL
$17.65 - $27.37 $38,547 - $59,776
-2,184 Reduced 13.76%
13,693 $360,000
Q3 2022

Nov 14, 2022

BUY
$22.62 - $32.54 $80,029 - $115,126
3,538 Added 28.67%
15,877 $368,000
Q2 2022

Aug 08, 2022

BUY
$22.88 - $39.45 $8,488 - $14,635
371 Added 3.1%
12,339 $311,000
Q1 2022

May 12, 2022

BUY
$31.69 - $43.29 $379,265 - $518,094
11,968 New
11,968 $457,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.76B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.